User Tools

Site Tools


supplements:start

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
supplements:start [2026/02/14 18:52] andrew2393cnssupplements:start [2026/02/14 18:57] (current) – [4) Pain / Inflammation] andrew2393cns
Line 21: Line 21:
   * [[supplements:st_johns_wort|St. John’s Wort]] → CYP induction → ↓ efficacy of [[psychiatry:ssri|SSRIs]], [[psychiatry:snri|SNRIs]], [[psychiatry:tca|TCAs]], [[drug_classes:oral_contraceptives|Oral Contraceptives]], [[drug_classes:transplant_immunosuppressants|Transplant Immunosuppressants]]   * [[supplements:st_johns_wort|St. John’s Wort]] → CYP induction → ↓ efficacy of [[psychiatry:ssri|SSRIs]], [[psychiatry:snri|SNRIs]], [[psychiatry:tca|TCAs]], [[drug_classes:oral_contraceptives|Oral Contraceptives]], [[drug_classes:transplant_immunosuppressants|Transplant Immunosuppressants]]
   * [[supplements:kava|Kava]] → hepatotoxicity risk (consider LFT monitoring)   * [[supplements:kava|Kava]] → hepatotoxicity risk (consider LFT monitoring)
-  * [[supplements:kratom|Kratom]] → opioid-like effects; dependence/withdrawal risk (see [[pain_management:drug_classes:start|Pain Management Drug Classes]])+  * [[supplements:kratom|Kratom]] → opioid-like effects; dependence/withdrawal risk (see [[neuro:opioids:start|Opioids]])
   * [[supplements:red_yeast_rice|Red Yeast Rice]] → statin-like (lovastatin analog) → similar risks as [[cardio:lipids:statins|Statins]] and myopathy risk with [[cardio:lipids:atorvastatin|Atorvastatin]] / [[cardio:lipids:rosuvastatin|Rosuvastatin]]   * [[supplements:red_yeast_rice|Red Yeast Rice]] → statin-like (lovastatin analog) → similar risks as [[cardio:lipids:statins|Statins]] and myopathy risk with [[cardio:lipids:atorvastatin|Atorvastatin]] / [[cardio:lipids:rosuvastatin|Rosuvastatin]]
   * [[supplements:biotin|High-dose Biotin]] → interferes with [[endocrine:thyroid:start|Thyroid]] labs and troponin interpretation   * [[supplements:biotin|High-dose Biotin]] → interferes with [[endocrine:thyroid:start|Thyroid]] labs and troponin interpretation
Line 40: Line 40:
   * [[endocrine:tzds:start|TZDs]] (e.g., [[endocrine:tzds:pioglitazone|Pioglitazone]])   * [[endocrine:tzds:start|TZDs]] (e.g., [[endocrine:tzds:pioglitazone|Pioglitazone]])
   * [[endocrine:insulin:start|Insulin]]   * [[endocrine:insulin:start|Insulin]]
-  * [[endocrine:glp1_gip_gra:glp1:start|GLP-1 Receptor Agonists]] (e.g., [[endocrine:glp1_gip_gra:glp1:semaglutide|Semaglutide]], [[endocrine:glp1_gip_gra:glp1:liraglutide|Liraglutide]]) +  * [[endocrine:glp1:start|GLP-1 Receptor Agonists]] (e.g., [[endocrine:glp1:semaglutide|Semaglutide]], [[endocrine:glp1:liraglutide|Liraglutide]]) 
-  * [[endocrine:glp1_gip:dual_glp-1_gip_incretin_agonists|Dual GLP-1/GIP Agonists]] (e.g., [[endocrine:glp1_gip_gra:incretin:tirzepatide|Tirzepatide]])+  * [[endocrine:glp1_gip:dual_glp-1_gip_incretin_agonists|Dual GLP-1/GIP Agonists]] (e.g., [[endocrine:incretin:tirzepatide|Tirzepatide]])
  
 Common supplements: Common supplements:
Line 105: Line 105:
  
 Common supplements: Common supplements:
 +  * [[supplements:kratom|Kratom]]
   * [[supplements:turmeric_curcumin|Turmeric / curcumin]]   * [[supplements:turmeric_curcumin|Turmeric / curcumin]]
   * [[supplements:omega_3_fatty_acids|Omega-3 fatty acids]]   * [[supplements:omega_3_fatty_acids|Omega-3 fatty acids]]
supplements/start.1771095137.txt.gz · Last modified: by andrew2393cns